Health ❯ Healthcare ❯ Clinical Trials ❯ Phase 3 Trials

Efficacy Studies

Pfizer’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

Regulatory uncertainty now determines whether the candidate advances to U.S. authorization.

FDA Approves Darzalex Faspro as First Therapy for High-Risk Smoldering Multiple Myeloma

FDA Expands Moderna RSV Vaccine to Adults 18–59 at Risk